MELANIE TALWAR-COLES
Alemtuzumab patient
United Kingdom

Diagnosed with multiple sclerosis (MS) in 1998 at age 23, Melanie quickly became dependent on others in her daily life. She was among the first to be enrolled in alemtuzumab for MS clinical trials in 2000. Today she is married with two children and happy she is able to "live again" after treatments.